박병탁 기자

Park Pyeongtak

Reporter
Biowatch Team With a background in Business Administration (MBA), I focus on the pharmaceutical and biotech industries. My goal is to select key information and present it in an easily understandable manner.
mail ppt@kormedi.com

Latest Articles

Sam Chun Dang Pharm Secures Exclusive U.S. Licensing Deal for Oral Obesity and Diabetes Treatment

Celltrion Secures Japanese Approval for Xolair and Eylea Biosimilars

Daewoong Pharmaceutical to Distribute 'The Spirokit' Digital Pulmonary Function Tester

Oscotec to Present Kidney Failure Treatment Candidate at World Congress of Nephrology in Japan

Alteogen to Present Subcutaneous ADC Formulation Research at International Forum in June

Alteogen Secures U.S. Patent Registration for Keytruda SC Formulation

Daewoong Pharmaceutical: Early Arrhythmia Detection Through Wearable ‘MobiCare’ Device

SK Chemicals Launches High-Dose 300 mg Joins for Osteoarthritis Treatment

Previous1011121314Next